Wearable devices to measure movement signs in Parkinson's disease
Studies movement signals from wearable devices in adults with Parkinson's disease.
Plain-language title generated from the registry record
Registry title: Digital BIOmarkers for the Assessment of Motor Status in Parkinson's Disease Patients with CLInical and ThErapeutic Application
Key facts
- Where
- Madrid, SpainSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 80 years old?
Source: NCT06817772, who can take part
Where in Spain
- Universidad Politécnica de MadridMadrid, SpainNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universidad Politecnica de Madrid
- Trial code
- NCT06817772
- Record updated
- 20 February 2025
- Original description
The goal of this observational study is to define digital biomarkers of motor symptoms in Parkinson's disease patients using wearable devices. The main questions it aims to answer is:Read full original descriptionShow less
Digital BIOmarkers for the Assessment of Motor Status in Parkinson's Disease Patients with CLInical and ThErapeutic Application
The goal of this observational study is to define digital biomarkers of motor symptoms in Parkinson's disease patients using wearable devices. The main questions it aims to answer is:
* Is there a biomarkers that allows the identification of PD from healthy controls? * Is there a biomarkers that can identify the severity of the disease? * Is there a biomarkers with clinical and therapeutic application that can be used in clinical and free living conditions to monitor the evolution of the disease?
Participants have to perform a set of guided exercises related to the MDS-UPDRS guide and daily living tasks, in supervised and unsupervised conditions.
Inclusion: Diagnosis of Parkinson's disease based on the UK Brain Bank criteria; Affiliated with Asociación Parkinson Madrid; Minimal or mild disease severity, defined by a Hoehn and Yahr scale score of ≤ 2.5; Be capable of performing the prescribed exercises independently; Maintain daily functioning without dependence on caregivers.
Exclusion: Have undergone deep brain stimulation, used dopamine infusion pumps, or have conditions mimicking PD symptoms (e.g., progressive supranuclear palsy, Lewy body dementia, multiple system atrophy, or other parkinsonian syndromes); Hoehn and Yahr scale score of > 2.5; Experience motor symptom fluctuations throughout the day.